These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 36941133)
1. Use of 1,3-Beta-D-Glucan concentration in peritoneal fluid for the diagnosis of intra-abdominal Candidiasis in Critically-ill patients. Nourry É; Wallet F; Darien M; Menotti J; Dupont D; Allaouchiche B; Argaud L; Richard JC; Guichon C; Rimmelé T; Bohe J; Thiollère F; Vassal O; Lepape A; Wallon M; Persat F; Friggeri A Med Mycol; 2023 Mar; ():. PubMed ID: 36941133 [TBL] [Abstract][Full Text] [Related]
2. Combination of serum and peritoneal 1.3-beta-D-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study. Novy E; Rivière J; Nguyen M; Arfeuille G; Louis G; Bouhemad B; Pottecher J; Hecketsweiler S; Germain A; Laithier FX; Losser MR; Debourgogne A; Bernard Y; Rousseau H; Baumann C; Luc A; Birckener J; Machouart MC; Guerci P Crit Care; 2023 Nov; 27(1):470. PubMed ID: 38037130 [TBL] [Abstract][Full Text] [Related]
3. Determination of 1,3-β-D-glucan in the peritoneal fluid for the diagnosis of intra-abdominal candidiasis in critically ill patients: a pilot study. Novy E; Laithier FX; Machouart MC; Albuisson E; Guerci P; Losser MR Minerva Anestesiol; 2018 Dec; 84(12):1369-1376. PubMed ID: 29991219 [TBL] [Abstract][Full Text] [Related]
4. Detection of Xie M; Shao J; Wan Z; Yan T; Zhu S; Li S; Yu J Front Microbiol; 2022; 13():1070688. PubMed ID: 36687581 [TBL] [Abstract][Full Text] [Related]
5. Is ß-d-glucan Relevant for the Diagnosis and Follow-Up of Intensive Care Patients with Yeast-Complicated Intra-Abdominal Infection? Dupont H; Malaquin S; Villeret L; Macq PY; Ammenouche N; Tinturier F; Diouf M; Rumbach M; Chouaki T J Fungi (Basel); 2022 May; 8(5):. PubMed ID: 35628743 [TBL] [Abstract][Full Text] [Related]
6. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial. Bloos F; Held J; Schlattmann P; Brillinger N; Kurzai O; Cornely OA; Thomas-Rüddel D Trials; 2018 Sep; 19(1):472. PubMed ID: 30180873 [TBL] [Abstract][Full Text] [Related]
7. Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study). Rinaldi M; Bartoletti M; Bonazzetti C; Caroccia N; Gatti M; Tazza B; Horna CS; Giannella M; Viale P Int J Antimicrob Agents; 2023 Dec; 62(6):106998. PubMed ID: 37838147 [TBL] [Abstract][Full Text] [Related]
8. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions. León C; Ruiz-Santana S; Saavedra P; Castro C; Loza A; Zakariya I; Úbeda A; Parra M; Macías D; Tomás JI; Rezusta A; Rodríguez A; Gómez F; Martín-Mazuelos E; Crit Care; 2016 May; 20(1):149. PubMed ID: 27181045 [TBL] [Abstract][Full Text] [Related]
9. Roles of the multiplex real-time PCR assay and β-D-glucan in a high-risk population for intra-abdominal candidiasis (IAC). Fortún J; Buitrago MJ; Gioia F; Gómez-Gª de la Pedrosa E; Alvarez ME; Martín-Dávila P; Pintado V; Cobeta P; Martinez-Castro N; Soriano C; Moreno I; Corral S; Muñoz P; Moreno-Jimenez G; Cuenca-Estrella M; Moreno-Guillen S Med Mycol; 2020 Aug; 58(6):789-796. PubMed ID: 31811285 [TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study. Bassetti M; Vena A; Giacobbe DR; Trucchi C; Ansaldi F; Antonelli M; Adamkova V; Alicino C; Almyroudi MP; Atchade E; Azzini AM; Brugnaro P; Carannante N; Peghin M; Berruti M; Carnelutti A; Castaldo N; Corcione S; Cortegiani A; Dimopoulos G; Dubler S; García-Garmendia JL; Girardis M; Cornely OA; Ianniruberto S; Kullberg BJ; Lagrou K; Lebihan C; Luzzati R; Malbrain M; Merelli M; Marques AJ; Martin-Loeches I; Mesini A; Paiva JA; Raineri SM; Rautemaa-Richardson R; Schouten J; Spapen H; Tasioudis P; Timsit JF; Tisa V; Tumbarello M; Van den Berg CHSB; Veber B; Venditti M; Voiriot G; Wauters J; Zappella N; Montravers P; Infect Dis Ther; 2022 Apr; 11(2):827-840. PubMed ID: 35182353 [TBL] [Abstract][Full Text] [Related]
12. A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Bassetti M; Marchetti M; Chakrabarti A; Colizza S; Garnacho-Montero J; Kett DH; Munoz P; Cristini F; Andoniadou A; Viale P; Rocca GD; Roilides E; Sganga G; Walsh TJ; Tascini C; Tumbarello M; Menichetti F; Righi E; Eckmann C; Viscoli C; Shorr AF; Leroy O; Petrikos G; De Rosa FG Intensive Care Med; 2013 Dec; 39(12):2092-106. PubMed ID: 24105327 [TBL] [Abstract][Full Text] [Related]
13. Sensitivity of Serum Beta-D-Glucan in Candidemia According to Mikulska M; Magnasco L; Signori A; Sepulcri C; Dettori S; Tutino S; Vena A; Miletich F; Ullah N; Morici P; Ball L; Pelosi P; Marchese A; Giacobbe DR; Bassetti M J Fungi (Basel); 2022 Aug; 8(9):. PubMed ID: 36135645 [TBL] [Abstract][Full Text] [Related]
14. Reappraisal of intra-abdominal candidiasis: insights from peritoneal fluid analysis. Novy E; Esposito M; Birckener J; Germain A; Losser MR; Machouart MC; Guerci P Intensive Care Med Exp; 2023 Sep; 11(1):67. PubMed ID: 37776390 [TBL] [Abstract][Full Text] [Related]
15. Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions. León C; Ruiz-Santana S; Saavedra P; Castro C; Ubeda A; Loza A; Martín-Mazuelos E; Blanco A; Jerez V; Ballús J; Alvarez-Rocha L; Utande-Vázquez A; Fariñas O Intensive Care Med; 2012 Aug; 38(8):1315-25. PubMed ID: 22752333 [TBL] [Abstract][Full Text] [Related]
16. β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis. Martín-Mazuelos E; Loza A; Castro C; Macías D; Zakariya I; Saavedra P; Ruiz-Santana S; Marín E; León C Intensive Care Med; 2015 Aug; 41(8):1424-32. PubMed ID: 26134359 [TBL] [Abstract][Full Text] [Related]
17. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients. Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024 [TBL] [Abstract][Full Text] [Related]
18. Clinical Profile of Non-neutropenic Patients with Invasive Candidiasis: A Retrospective Study in a Tertiary Care Center. Sridharan S; Gopalakrishnan R; Nambi PS; Kumar S; Sethuraman N; Ramasubramanian V Indian J Crit Care Med; 2021 Mar; 25(3):267-272. PubMed ID: 33790505 [No Abstract] [Full Text] [Related]
19. Serial (1-3)-beta-D-Glucan (BDG) monitoring shows high variability among premature neonates. Ferreras-Antolin L; Aziz N; Warris A Med Mycol; 2022 Jun; 60(6):. PubMed ID: 35561703 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies. Sganga G; Wang M; Capparella MR; Tawadrous M; Yan JL; Aram JA; Montravers P Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1849-1856. PubMed ID: 31280481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]